Why did the 2289.HK stock jump today

The intraday jump was driven by a volume surge (1,000 vs avg 441) and buying pressure at the open. Technical momentum (RSI 60.49, ADX 38.74) amplified the move. No single public catalyst was released; traders reacted to liquidity and valuation signals.

What are the valuation metrics for 2289.HK stock

Charmacy trades at PE **14.62**, price-to-book **1.19**, price-to-sales **0.17**, and offers a dividend yield of about **6.69%**. These metrics suggest value relative to many healthcare peers but reflect higher leverage.

What does Meyka AI forecast for 2289.HK stock

Meyka AI's forecast model projects **monthly HK$6.12**, **quarterly HK$5.01**, and **yearly HK$3.25**. Models imply downside versus today's price; forecasts are projections and not guarantees.

How should traders approach 2289.HK stock after the spike

Use scaled entries, tight stops, and profit targets. Short-term traders can target **HK$8.50** with protective stops below **HK$6.50**. Size positions modestly given thin intraday volume.

HK Stocks

2289.HK Charmacy (HKSE) up 23.90% to HK$7.31 on 23 Jan 2026: volume-led move

ByDanny Kontos January 23, 2026January 23, 2026

The 2289.HK stock jumped 23.90% to HK$7.31 intraday on 23 Jan 2026 on the Hong Kong Stock Exchange (HKSE). The price rise came with a volume spike — 1,000 shares vs average 441, a relative volume of 2.27, marking the stock among today’s high-volume movers. Traders are reacting to fresh buying interest; we track valuation, technicals, and Meyka AI model forecasts to explain the move and short-term outlook for Charmacy Pharmaceutical Co., Ltd.